Switching Between Biologics and Targeted Synthetic Therapies Due to Inefficacy in Psoriatic Arthritis

被引：0
|
作者：
Freites Nunez, Dalifer [1 ]
Rodriguez Laguna, Maria [1 ]
Hormigos Martin, Cristina [1 ]
Rosales, Zulema [1 ]
Leon, Leticia [2 ]
Candelas, Gloria [1 ]
Rubio, Daniel [3 ]
Otazu, Jose [1 ]
Fernandez, Benjamin [1 ]
Abasolo, Lydia [1 ]
机构：
[1] Hosp Clin San Carlos, Madrid, Spain
[2] Fdn Invest Biomed Hosp Clin San Carlos, Madrid, Spain
[3] Univ Complutense Madrid, Madrid, Spain
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2244
引用
收藏
页码：4438 / 4440
页数：3
相关论文
共 50 条
  • [41] Choosing between Targeted Therapies for Rheumatoid Arthritis Patients: The Oncology Perspective
    Bongartz, Tim
    [J]. CURRENT RHEUMATOLOGY REVIEWS, 2011, 7 (01) : 70 - 76
  • [42] Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register
    Saad, Amr A.
    Ashcroft, Darren M.
    Watson, Kath D.
    Symmons, Deborah P. M.
    Noyce, Peter R.
    Hyrich, Kimme L.
    [J]. RHEUMATOLOGY, 2010, 49 (04) : 697 - 705
  • [43] Is precision medicine possible in rheumatic diseases? Lessons from selective use of targeted therapies in patients with psoriatic arthritis
    Miyagawa, Ippei
    Tanaka, Yoshiya
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (02) : 199 - 206
  • [44] Effect of biologics and targeted synthetic disease-modifying anti-rheumatic drugs on fatigue in rheumatoid arthritis
    Choy, Ernest H.
    [J]. RHEUMATOLOGY, 2019, 58 : 51 - 55
  • [45] Comment on: Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register
    Coates, Laura C.
    Helliwell, Philip S.
    [J]. RHEUMATOLOGY, 2010, 49 (09) : 1793 - 1794
  • [46] Reasons for multiple biologic and targeted synthetic DMARD switching and characteristics of treatment refractory rheumatoid arthritis
    Mcdermott, Gregory C.
    Diiorio, Michael
    Kawano, Yumeko
    Jeffway, Mary
    Macvicar, Megan
    Dahal, Kumar
    Moon, Su-Jin
    Seyok, Thany
    Coblyn, Jonathan
    Massarotti, Elena
    Weinblatt, Michael E.
    Weisenfeld, Dana
    Liao, Katherine P.
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 66
  • [47] UPTAKE OF NEWER BIOLOGIC AND TARGETED SYNTHETIC DMARDS IN PSORIATIC ARTHRITIS, RESULTS FROM FOUR NORDIC BIOLOGIC REGISTRIES
    Glintborg, B.
    Di Giuseppe, D.
    Wallman, J. K.
    Nordstrom, D.
    Gudbjornsson, B.
    Hetland, M. L.
    Askling, J.
    Grondal, G.
    Sokka-Isler, T.
    Provan, S. Aarrestad
    Lindstrom, U.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 766 - 767
  • [48] Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study
    Fagerli, Karen Minde
    Lie, Elisabeth
    van der Heijde, Desiree
    Heiberg, Marte Schrumpf
    Kalstad, Synove
    Rodevand, Erik
    Mikkelsen, Knut
    Lexberg, Ase Stavland
    Kvien, Tore K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (11) : 1840 - 1844
  • [49] Synovial Tissue Heterogeneity in Rheumatoid Arthritis and Changes With Biologic and Targeted Synthetic Therapies to Inform Stratified Therapy
    Ouboussad, Lylia
    Burska, Agata N.
    Melville, Andrew
    Buch, Maya H.
    [J]. FRONTIERS IN MEDICINE, 2019, 6
  • [50] Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register
    Amr A Saad
    Darren M Ashcroft
    Kath D Watson
    Kimme L Hyrich
    Peter R Noyce
    Deborah PM Symmons
    [J]. Arthritis Research & Therapy, 11
12345